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GYNAECOLOGICAL PRODUCT DEVELOPMENT FACILITATED 
THROUGH RP AND RAPID TOOLING 
L.J. Barnard, G.J. Booysen and D.J. de Beer 
ABSTRACT
Atkinson (1) distinguishes between four types of prototypes, categorised through 
its end-use: 
• Design or aesthetic prototypes 
• Geometrical prototypes 
• Functional prototypes 
• Technological prototypes 
Shigley and Mitchell (3) define the design process according to the following six 
phases:
Recognition of need 
Definition of problem 
Synthesis
Analysis and optimization 
Evaluation
Presentation 
The Centre for Rapid Prototyping and Manufacture (CRPM) of the Central 
University of Technology, Free State was asked to assist in the development of a 
newly developed gynaecological cream applicator. Apart from needing a freeform 
fabrication system to give form fit and function to the very complex design, the 
product needed Rapid Tooling/Rapid Manufacturing support to enable a first 
batch production for medical trials and evaluation. The paper will describe the 
total product development process alongside prototype categories described by 
Atkinson (1) and design phases defined by Shigley and Mitchell (3) (including 
some iterations enabled through timeous prototyping, including various Rapid 
Prototyping (RP) Technologies, soft tooling and vacuum casting). More 
importantly, results from Rapid Tooling for limited run production (due to the 
complexity of the product the cycle time of the Prototype Tool is fairly long), as 
well as the economical impact made possible through the support of CAD/CAM 
and RP Technologies, will be discussed. 
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1.  INTRODUCTION 
The CPRM was requested by a gynaecologist to develop a vaginal cream 
applicator that could be used comfortably and without problems. Women who 
need to use this cream applicator are mostly pregnant or elderly, and need to get 
hormone supplement. In some cases woman with vaginal infection also need to 
use antibiotics cream. The product needs to apply a constant dosage of the 
cream where needed, without irritating the vaginal sides. The applicator must 
furthermore reduce the possibility of infection or transfer of organisms. Therefore 
the tip of the product should be formed in such a way that no sharp edges occur 
and that the least possible amount of cream or vaginal fluids are trapped in the 
opening at the front after application. The application bubble should not suck in 
any cream or air when it is released, and thus should be very thin. The shape of 
the product should be based on the shape of the opening of the vagina. The 
product had to be flexible so as to flex to a limited extent not to harm the user. 
2.  DESIGN BRIEF 
Already practicing for 25 years, the gynaecologist had been confronted with bad 
designs of cream applicators. In explaining the use of the applicator to his 
patients, he recognised the need for a better-designed product. 
The problem was defined by both the difficulty of use and the discomfort while 
using the existing product. A freeform design was needed to produce a product, 
acceptable and functional for the women needing it. In order to support the 
inventor’s claim, it was necessary to design and manufacture a product that 
incorporated the required functionality. Product aesthetics played an important 
role, as if there would be resistance by the women using it the product was 
destined to fail. 
The following requirements had to be met in the design: 
• The applicator had to be fixed to the cream by screwing it onto the tube. 
• It had to form an angle of 23° with the center-axis of the cream tube, to
ensure easy access of the applicator into the vagina without any problems for 
the user. (This will ensure that pregnant and older women would be able to 
use it comfortably. The user can take the tube in her hand and the angle 
which the vagina forms with the centre of the body will then be the same.) 
• A circular volume (ball) of which the cavity is equal to the volume of cream 
needed, had to be placed in front of the threaded collar. The side-walls of the 
ball was designed as thin as possible, so that when it is squeezed, it would 
remain in that position without sucking new cream out of the tube and into the 
applicator. 
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• The applicator-ball needed ribs on both sides to provide stability of the tube 
while inserting the shaft into the vagina.
• The applicator-shaft needed to be flex ble but also stable enough so that it 
does not fold or deflect when inserted. 
• The channel through which the cream is injected must be thin enough to hold 
the smallest quantity of cream possible, but still accommodates free-flowing 
of the cream with as little as poss ble flow resistance. 
3. DEVELOPMENT PROCESS 
3.1  CAD design 
The design was completed on CAD and analysed by the customer and his 
patients. The internal volume could be calculated, using the CAD data. A few 
minor aesthetic changes were made and applied to the design. A prototype was 
grown to enable better representation of the design. Figure 1 shows the 
completed design. Figure 2 shows the CAD of the core. The complexity can be 
seen in the design. 
Figure 1: CAD design of cream applicator 
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Figure 2: Design of the core 
3.2  Prototyping of cream applicator 
The design was grown on the Stereolithography (SLA) in Somos 9110 resin. The 
initial prototyping was done to ensure that the aesthetics are acceptable to the 
users.
Figure 3 shows an image of the completed SLA prototype. 
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Figure 3: SLA prototype 
4.  RESULTS 
4.1  Evaluation of the prototype 
The prototype was sent to the customer, who consulted other gynaecologists and 
patients (as poss ble consumers). A few minor design iterations were made and 
the design was approved.
4.2  Limited production tooling 
For limited production quantities, vacuum casting and silicone tooling can be 
used. However, although initially only 50 parts were needed, it was decided to 
develop a prototype tool for injection moulding, supporting the following prototype 
testing and evaluation needs: 
• In order to ensure that the dosage would be exactly 6g, a prototype had to be 
manufactured from a flexible material to measure the delivered dosage with 
an electronic scale. 
• Clinical tests would only be allowed if the product was manufactured in the 
final Food and Drug Administration (FDA) approved injection moulded rubber. 
Therefore, it was decided not to manufacture a vacuum casting mould but to 
directly manufacture an injection-moulding tool. 
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Being a prototype tool for limited production of parts, an existing bolster was 
used to accommodate the insert. It was decided to manufacture a hand-operated 
tool where the core will be manually pulled out of the product. The bottom and 
top half of the tool was manufactured from Aluminium by means of a three-axis 
CNC milling machine. Figure 4 shows a machined bottom half of the tool. 
Figure 4: Machined bottom half of the tool
The shape of the product’s corresponding core was very complex and needed 
five-axes CNC machining. Not having direct access to five-axes CNC machining, 
it was decided to grow a core with a DTM SLS 2000 machine, using ST-100 (2)
steel. As seen from Figure 2, the design included a high level of complexity and 
detail, such as the ribs on the side of the ball, as well as a very thin and long 
shaft - all problematic for machining. By growing the core in ST-100, the product 
could be tested and the design (and corresponding core geometry) adjusted until 
the correct dosage was reached. Figures 2 and 5 show the core design and 
prototyped core in ST-100. 
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Figure 5: ST-100 grown core  
4.3  Manufacturing of functional prototypes 
Injection moulding was done through a single-cavity tool. The moulded part 
(including the core) had to be removed from the tool by hand, following the hand-
removal of the core from the product. After each cycle the core had to be hand-
placed in the tool again, before a next cycle could start. The cycle time of 135 
seconds/product was lengthy, but was sufficient to manufacture the 50 products 
needed for clinical tests. Figure 6 and 7 show the completed prototype tool and 
the final part from the tool. 
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Figure 6: Prototype tool 
Figure 7: Functional prototype 
21
5.  DISCUSSION 
5.1  Economical impact of the Product Development Process 
The gynaecologist was quoted R250 000 (32 000 euros) for a double cavity 
production tool. As the product was not proven yet (neither in terms of 
functionality, or accuracy of the dosage), the client could not consider 
manufacturing of the moulds, and thus had no way of proving the product. 
In order to market the idea to pharmaceutical companies, clinical trials are 
needed, which in turn required products manufactured from FDA approved 
materials. Furthermore, products in the FDA material are required to test the 
dosage, and if not correct, to use the results for design iteration. This could lead 
to series of redesign and remanufacturing to get to a final proven stage. 
In terms of normal risk analysis, there were too many unanswered decision 
making factors, leaving no other answer as that no economical solution was 
poss ble – also leaving pharmaceutical companies and poss ble venture capital 
firms no other option as to decline the product or deny it development support. 
Using the different available technologies and stages discussed, the client 
invested/spent R32 000 (4000 Euros) on the product. Taking a decision to place 
an order for the production tool, subjected to possible redesign or tool changes, 
could have resulted in production costs exceeding one order of magnitude higher 
than was spent. 
The technologies as used resulted in final products, which could be used to 
market the product to pharmaceutical companies without spending money on the 
production tool, prior to having orders. Final orders will enable a decision to 
support the manufacturing of a suitable size production tool according to the 
magnitude of orders placed. 
6.  CONCLUSIONS 
Shigley and Mitchell (3) define the Design Process as an interactive procedure 
consisting of six phases, namely recognition of need; definition of problem; 
synthesis; analysis and optimisation; evaluation and presentation. The first step 
arises from a specific need, or identified problem. Step two defines the 
boundaries in which the designer/design team should operate, and may predict
the expected or required outcomes. The boundaries set out in the definition 
should indicate the constraints and criteria to be met with the design or 
development, and should ultimately be applicable for evaluation of the product. 
Such criteria should set out the parameters, which could be used to evaluate the 
design. Following the definition of the problem, synthesis, analysis and 
optimisation (the next three steps) are iterative processes, and are performed in 
conjunction with each other, as part of the optimisation process. A design is 
created to meet all constraints (synthesised) and then analysed to determine 

